New breathing treatment for babies with bronchiolitis never tested
NCT ID NCT01229384
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This trial aimed to compare standard nebulized breathing treatments with a positive pressure device in infants aged 2-24 months with moderate to severe bronchiolitis. The goal was to see if the pressurized method reduced hospital admissions. However, the study was withdrawn before enrolling any participants, so no data were collected.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
albuterol and racemic epinephrine delivered via positive pressure nebulization device
What this could lead to
If it worked, this could show a better way to deliver breathing treatments to infants with bronchiolitis, potentially reducing hospital stays.
What could go wrong
The study was withdrawn before any patients were enrolled, so no results exist. The approach is still experimental and unproven.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRONCHIOLITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.